07:51 AM EDT, 07/03/2025 (MT Newswires) -- LSL Pharma Group (LSL.V) overnight Wednesday said that TSX Trust Company will be providing notice of early redemption of all of the company's outstanding $3.28 million in 11% unsecured convertible debentures, originally due October 31, 2028.

The company said that the redemption is being carried out in accordance with the trust indenture dated November 1, 2023 between LSL Pharma and TSX Trust Company, who is the Trustee.

The convertible debentures, which are listed on the TSX Venture Exchange, will be redeemed by the Trustee on August 4 and will cease trading on the redemption date, in accordance with TSXV policies.

Holders of convertible debentures will receive $10.40 for each $10 principal amount of convertible debentures plus all accrued and unpaid interest up to but excluding the redemption date.